Cargando…

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

BACKGROUND: Fibroblast growth factor receptor 1 (FGFR1) is correlated closely with the occurrence and development of lung cancer. FGFR1 kinase inhibitors have exhibited significant therapeutic effects against non-small-cell lung cancer. Recently, non-ATP competitive FGFR1 inhibitors have attracted e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianzhang, Wei, Tao, Tang, Qinqin, Weng, Bixia, Li, Wulan, Jiang, Xin, Ding, Ting, Li, Xiaokun, Liang, Guang, Cai, Yuepiao, Ji, Jiansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410475/ https://www.ncbi.nlm.nih.gov/pubmed/25880284 http://dx.doi.org/10.1186/s12885-015-1307-9

Ejemplares similares

Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo
por: Wu, Jianzhang, et al.
Publicado: (2014)

Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
por: Liu, Yanan, et al.
Publicado: (2020)

Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells
por: Liu, Zhiguo, et al.
Publicado: (2013)

(E)-1-(4-Methoxyphenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one
por: Cai, Yuepiao, et al.
Publicado: (2011)

Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor
por: Michaelides, Iacovos N., et al.
Publicado: (2023)

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
por: Yuan, Hong, et al.
Publicado: (2017)

OTUB1 inhibits breast cancer by non‐canonically stabilizing CCN6
por: Zhao, Ying, et al.
Publicado: (2023)

An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
por: Quan, Mei-Yu, et al.
Publicado: (2020)

FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
por: Ying, Xihui, et al.
Publicado: (2019)

Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
por: Quan, Mei-Yu, et al.
Publicado: (2020)

Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect
por: Chen, Qian, et al.
Publicado: (2020)

Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
por: Zhou, Zhen, et al.
Publicado: (2021)

FGFR1 amplification and the progression of non-invasive to invasive breast cancer
por: Gru, Alejandro A, et al.
Publicado: (2012)

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012)

FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway
por: Ji, Wenxiang, et al.
Publicado: (2016)

In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2
por: Alberca, Lucas N., et al.
Publicado: (2019)

Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib
por: van der Veen, Lars, et al.
Publicado: (2023)

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer
por: Theelen, Willemijn SME, et al.
Publicado: (2016)

Novel non-ATP competitive small molecules targeting the CK2 α/β interface
por: Brear, Paul, et al.
Publicado: (2018)

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
por: Dutt, Amit, et al.
Publicado: (2011)

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021)

Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
por: Blaser, Benjamin, et al.
Publicado: (2012)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Inhibitors in AKTion: ATP-competitive vs allosteric
por: Lazaro, Glorianne, et al.
Publicado: (2020)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
por: Wang, Cong, et al.
Publicado: (2019)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents
por: Liu, Yu, et al.
Publicado: (2016)

A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties
por: Pitman, Melissa R., et al.
Publicado: (2015)

Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)
por: Pascual, Isel, et al.
Publicado: (2017)

Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review
por: Zheng, Jia, et al.
Publicado: (2022)

miR-802 inhibits the aggressive behaviors of non-small cell lung cancer cells by directly targeting FGFR1
por: Zhang, Jiexia, et al.
Publicado: (2022)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
por: Raoof, Sana, et al.
Publicado: (2019)

Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells
por: Jin, Rong, et al.
Publicado: (2016)

Rational Design and Synthesis of D‐galactosyl Lysophospholipids as Selective Substrates and non‐ATP‐competitive Inhibitors of Phosphatidylinositol Phosphate Kinases
por: Sun, Mengxia, et al.
Publicado: (2022)

FGFR-TKI resistance in cancer: current status and perspectives
por: Yue, Sitong, et al.
Publicado: (2021)

Pyroptosis: A new insight of non-small-cell lung cancer treatment
por: Chen, Xi, et al.
Publicado: (2022)

FGFR4 and TGF-β1 Expression in Hepatocellular Carcinoma: Correlation with Clinicopathological Features and Prognosis
por: Chen, Zhixin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r0tne80hp5u79rtter4j9e1bgb